Polatuzumab Vedotin联合苯达莫司汀及利妥昔单抗（pola-BR）对比苯达莫司汀联合利妥昔单抗（BR）治疗复发/难治性DLBCL的疗效分析
评价者:应志涛1, 文献合成者:黄玲2

The Efficacy of Polatuzumab Vedotin with Bendamustine and Rituximab （pola-BR） versus Bendamustine and Rituximab （BR） in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Reviewer: YING Zhi-tao1, Literature Co-worker: HUANG Ling2